Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Schmalzing

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Zeitschrift Fur Rheumatologie|January 24, 2025
[T-cell large granular lymphocytic leukemia and Felty's syndrome in rheumatoid arthritis]Michael Gernert, Eva Christina Schwaneck, Marc Schmalzing
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 11, 2025
Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on VaccinationJohanna Stoevesandt, Marc Schmalzing, Sophia Mohme, et al.
European Journal of Dermatology : EJD|February 6, 2025
Anti-Mi-2-positive dermatomyositis with subclinical cardiac involvementSimon Goller, Tassilo Dege, Marc Schmalzing, et al.
Zeitschrift Fur Rheumatologie|October 10, 2025
[Digital health applications and axial spondyloarthritis]Patrick-Pascal Strunz, Uta Kiltz, David Kiefer, et al.
Dermatologie (Heidelberg, Germany)|September 1, 2025
[Lupus erythematosus]Patrick-Pascal Strunz, Marc Schmalzing, Matthias Goebeler, et al.
Clinical Rheumatology|March 15, 2025
Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?Lea-Kristin Nagler, Marc Schmalzing, Nora Isberner, et al.
Frontiers in Immunology|March 20, 2023
Editorial: Stem cell transplantation in autoimmune diseases (AID)Marc Schmalzing, Joerg Henes, Jacob M van Laar, et al.
Therapeutic Advances in Musculoskeletal Disease|December 2, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experienceMichael Gernert, Jörg Henes, Patrick-Pascal Strunz, et al.
Frontiers in Immunology|October 12, 2020
Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis PatientsZafar Mahmood, Marc Schmalzing, Thomas Dörner, et al.
Frontiers in Immunology|February 3, 2022
Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of RituximabMichael Gernert, Hans-Peter Tony, Matthias Fröhlich, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Zeitschrift Fur Rheumatologie|January 24, 2025
[T-cell large granular lymphocytic leukemia and Felty's syndrome in rheumatoid arthritis]Michael Gernert, Eva Christina Schwaneck, Marc Schmalzing
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 11, 2025
Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on VaccinationJohanna Stoevesandt, Marc Schmalzing, Sophia Mohme, et al.
European Journal of Dermatology : EJD|February 6, 2025
Anti-Mi-2-positive dermatomyositis with subclinical cardiac involvementSimon Goller, Tassilo Dege, Marc Schmalzing, et al.
Zeitschrift Fur Rheumatologie|October 10, 2025
[Digital health applications and axial spondyloarthritis]Patrick-Pascal Strunz, Uta Kiltz, David Kiefer, et al.
Dermatologie (Heidelberg, Germany)|September 1, 2025
[Lupus erythematosus]Patrick-Pascal Strunz, Marc Schmalzing, Matthias Goebeler, et al.
Clinical Rheumatology|March 15, 2025
Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?Lea-Kristin Nagler, Marc Schmalzing, Nora Isberner, et al.
Frontiers in Immunology|March 20, 2023
Editorial: Stem cell transplantation in autoimmune diseases (AID)Marc Schmalzing, Joerg Henes, Jacob M van Laar, et al.
Therapeutic Advances in Musculoskeletal Disease|December 2, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experienceMichael Gernert, Jörg Henes, Patrick-Pascal Strunz, et al.
Frontiers in Immunology|October 12, 2020
Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis PatientsZafar Mahmood, Marc Schmalzing, Thomas Dörner, et al.
Frontiers in Immunology|February 3, 2022
Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of RituximabMichael Gernert, Hans-Peter Tony, Matthias Fröhlich, et al.
Pageof 14